Pharmacologic Augmentation of Targeted Cognitive Training in Schizophrenia
NCT04414930
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Schizoaffective Disorder
Interventions
DRUG:
d-amphetamine
DRUG:
Placebo
Sponsor
University of California, San Diego